Akebia Therapeutics (AKBA) Payables (2013 - 2026)
Akebia Therapeutics (AKBA) reported Payables of $9.42 million for Q2 2026, down 18.5% from $11.55 million a year earlier but up 12.4% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Akebia Therapeutics posted Payables of $21.19 million, up 39.6% from FY2024.
- Payables has a five-year compound annual growth rate of -12.5% (FY2020 to FY2025).
- By year, Payables came in at $15.18 million in FY2024 (+3.7%), $14.64 million in FY2023 (-18.8%), $18.02 million in FY2022 (-46.3%) and $33.59 million in FY2021 (-18.7%).
- Five-year quarterly Payables spans a low of $8.39 million in Q1 2026 and a high of $33.59 million in Q4 2021.
- Year over year, Payables gained in five of the last eight quarters, with growth averaging 4.5%.
- The high point for year-over-year Payables in five years was Q3 2024 (growth of 49.3%); the low point was Q3 2023 (a decline of 54.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.39 million (Q1 2026), $21.19 million (Q4 2025) and $10.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn | 9.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.42 Mn |
| Mar 31, 2026 | 8.39 Mn |
| Dec 31, 2025 | 21.19 Mn |
| Sep 30, 2025 | 10.09 Mn |
| Jun 30, 2025 | 11.55 Mn |
| Mar 31, 2025 | 12.66 Mn |
| Dec 31, 2024 | 15.18 Mn |
| Sep 30, 2024 | 13.49 Mn |
| Jun 30, 2024 | 10.11 Mn |
| Mar 31, 2024 | 11.88 Mn |
| Dec 31, 2023 | 14.64 Mn |
| Sep 30, 2023 | 9.04 Mn |
| Jun 30, 2023 | 11.78 Mn |
| Mar 31, 2023 | 12.58 Mn |
| Dec 31, 2022 | 18.02 Mn |
| Sep 30, 2022 | 19.71 Mn |
| Jun 30, 2022 | 24.94 Mn |
| Mar 31, 2022 | 19.47 Mn |
| Dec 31, 2021 | 33.59 Mn |
| Sep 30, 2021 | 28.81 Mn |
API Access
Akebia Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();